SEC 13F Intelligence

Managers / Q2 2025 · view latest →

GTCR LLC

CIK 0001576350 · 300 N. LASALLE STREET, SUITE 5600, CHICAGO, IL, 60654 · 312-382-2200

Reported Value
$937M
Q2 2025
Positions
3
Filings on Record
24
2019–present window
Filed
Aug 14, 2025
original filing

Summary

Gtcr LLC reported $937M in U.S.-listed holdings across 3 positions for Q2 2025.

The portfolio is heavily concentrated: SHC alone accounts for 58.4% of reported value.

The book was largely unchanged from Q1 2025.

Portfolio Metrics

Turnover
+2.9%
vs prior filed quarter
Largest Position
+58.4%
Sotera Health

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’20: $4.0BQ4 ’20Q1 ’21: $3.5BQ2 ’21: $3.6BQ3 ’21: $3.9BQ3 ’21Q4 ’21: $3.3BQ1 ’22: $3.2BQ2 ’22: $2.8BQ2 ’22Q3 ’22: $1.7BQ4 ’22: $1.7BQ1 ’23: $2.0BQ1 ’23Q2 ’23: $2.1BQ3 ’23: $1.6BQ4 ’23: $1.6BQ4 ’23Q1 ’24: $1.2BQ2 ’24: $1.2BQ3 ’24: $1.3BQ3 ’24Q4 ’24: $1.0BQ1 ’25: $892MQ2 ’25: $937MQ2 ’25Q3 ’25: $906MQ4 ’25: $602MQ1 ’26: $3.8BQ1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 100.0%
  • Common Stock · 100.0% · $937M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
GOGOGOGO INCTRIMMED−8.50M23.24M+$68M$341M
SHCSOTERA HEALTH COHELD+049.22M−$27M$547M
MRVIMARAVAI LIFESCIENCES HLDGS IHELD+020.15M+$4M$49M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2025

3 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1SHCSOTERA HEALTH COhistory →COM58.41%$547M49.22M
2GOGOGOGO INChistory →COM36.41%$341M23.24M
3MRVIMARAVAI LIFESCIENCES HLDGS Ihistory →COM CL A5.18%$49M20.15M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$3.8B6May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$602M4Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$906M3Nov 13, 202513F-HRchanges · EDGAR ↗
Q2 2025$937M3Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$892M3May 14, 202513F-HRchanges · EDGAR ↗
Q4 2024$1.0B3Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$1.3B4Nov 13, 202413F-HRchanges · EDGAR ↗
Q2 2024REVEALED$1.2B4Aug 9, 202413F-HRchanges · EDGAR ↗
Q1 2024$1.2B3May 14, 202413F-HRchanges · EDGAR ↗
Q4 2023$1.6B3Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$1.6B3Nov 13, 202313F-HRchanges · EDGAR ↗
Q2 2023$2.1B3Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$2.0B3May 12, 202313F-HRchanges · EDGAR ↗
Q4 2022$1.7B4Jan 26, 202313F-HRchanges · EDGAR ↗
Q3 2022$1.7B4Nov 15, 2022RESTATEMENTchanges · EDGAR ↗
Q2 2022$2.8B4Jul 19, 202213F-HRchanges · EDGAR ↗
Q1 2022$3.2B4May 10, 202213F-HRchanges · EDGAR ↗
Q4 2021$3.3B4Feb 11, 202213F-HRchanges · EDGAR ↗
Q3 2021$3.9B4Nov 1, 202113F-HRchanges · EDGAR ↗
Q2 2021$3.6B4Aug 5, 202113F-HRchanges · EDGAR ↗
Q1 2021$3.5B5May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$4.0B5Feb 16, 202113F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.